The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Open accessAbstract
Chronic viral infections often result in T cell exhaustion. To determine the molecular signature of exhaustion, we compared the gene-expression profiles of dysfunctional lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells from chronic infection to functional LCMV-specific effector and memory CD8(+) T cells generated after acute infection. These data showed that exhausted CD8(+) T cells: (1) overexpressed several inhibitory receptors, including PD-1, (2) had major changes in T cell receptor and cytokine signaling pathways, (3) displayed altered expression of genes involved in chemotaxis, adhesion, and migration, (4) expressed a distinct set of transcription factors, and (5) had profound metabolic and bioenergetic deficiencies. T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes. Thus, functional exhaustion is probably due to both active suppression and passive defects in signaling and metabolism. These results provide a framework for designing rational immunotherapies during chronic infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T cells acquiring multiple inhibitory surface molecules in persistent disease settings such as chronic infection [37,38] and malignancies [30,**39,40], which effectively prevent T cell activation.”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [37]
In the citing paper
“Secretion of TNF-α in some populations of cells is reduced because of the contemporary arrest of p38-MAPK and PD-1 pathways.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“However, the telomerase activity in CD8+/CD45RA+ T cells is improved by blocking only the p38 pathway but not the PD-1 signaling, indicating that non-overlapping signaling pathways are involved (193, 194).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“In these cells that present characteristics of immune senescence (decreased proliferation, lower telomerase activity, and increased presence of DNA damage), the simultaneous blockade of both p38-MAPK and PD-1 signaling supports their proliferation, both in young and in older human beings.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationGreenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Self-citationWherry, E. J., Blattman, J. N., Murali‐Krishna, K., der Most, R. G. V., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,645
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,007
Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells
Provine, N. M., Larocca, R. A., Aïd, M., Penaloza‐MacMaster, P., Badamchi-Zadeh, A., Borducchi, E. N., Yates, K. B., Abbink, P., Kirilova, M., Ng’ang’a, D., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600591 · Cited by 58
Self-citationLi, J., Shayan, G., Avery, L., Jie, H.-B., Gildener‐Leapman, N., Schmitt, N. C., Lü, B., Kane, L., & Ferris, R. L. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1200778 · Cited by 58
Taner, T., Gustafson, M. P., Hansen, M. J., Park, W. D., Bornschlegl, S., Dietz, A. B., & Stegall, M. D. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.022 · Cited by 57
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
Aggen, D. H., Drake, C. G., & Rini, B. I. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3323 · Cited by 57
Thampy, L. K., Remy, K. E., Walton, A. H., Hong, Z., Liu, K., Liu, R., Yi, V. N., Burnham, C. D., & Hotchkiss, R. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199497 · Cited by 56
A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis
Darden, D. B., Dong, X., Brusko, M., Kelly, L. S., Fenner, B. P., Rincon, J. C., Dirain, M. L. S., Ungaro, R. F., Nacionales, D. C., Gauthier, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696536 · Cited by 58
Li, Q., Zhang, C., Xu, G., Shang, X., Nan, X., Li, Y., Liu, J., Hong, Y., Wang, Q., & Peng, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116172 · Cited by 57
Braga, F. A. V., Hertoghs, K. M. L., van Lier, R. A. W., & van Gisbergen, K. P. J. M. (2015) · European Journal of Immunology · doi:10.1002/eji.201545495 · Cited by 56
Immunotherapeutic effects of IL-7 during a chronic viral infection in mice
Nanjappa, S. G., Kim, E. H., & Suresh, M. (2011) · Blood · doi:10.1182/blood-2010-12-323154 · Cited by 56
Kallemeijn, M. J., Boots, A. M. H., van der Klift, M. Y., Brouwer, E., Abdulahad, W. H., Verhaar, J. A. N., van Dongen, J. J. M., & Langerak, A. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-05849-1 · Cited by 57
Sorensen, M. R., Holst, P. J., Steffensen, M. A., Christensen, J. P., & Thomsen, A. R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.066 · Cited by 55
Bakadia, B. M., He, F., Souho, T., Lamboni, L., Ullah, M. W., Boni, B. O. O., Ahmed, A. A. Q., Mukole, B. M., & Yang, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111008 · Cited by 56
Khan, S. M., Desai, R. R., Coxon, A. T., Livingstone, A. J., Dunn, G. P., Petti, A. A., & Johanns, T. M. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005293 · Cited by 60
Cruz, A. S., Mendes‐Frias, A., Azarias-da-Silva, M., André, S., Oliveira, A. I., Pires, O., Mendes, M., Oliveira, B., Braga, M., Lopes, J. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37368-1 · Cited by 54
Iannello, A., Débbeche, O., Samarani, S., & Ahmad, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907649 · Cited by 55
Flutter, B. R., Edwards, N., Fallah‐Arani, F., Henderson, S. R., Chai, J., Sivakumaran, S., Ghorashian, S., Bennett, C. L., Freeman, G. J., Sykes, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41446 · Cited by 56
Ingram, J. T., Yi, J. S., & Zajac, A. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002273 · Cited by 55
Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
Murter, B., Pan, X., Ophir, E., Alteber, Z., Azulay, M., Sen, R., Levy, O., Dassa, L., Vaknin, I., Kfir, T. F., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0460 · Cited by 55
Zhang, Z., Jin, B., Zhang, J., Xu, B., Wang, H., Shi, M., Wherry, E. J., Lau, G. K. K., & Wang, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.026 · Cited by 54
Self-citationThe Role of Metabolic Dysfunction in T-Cell Exhaustion During Chronic Viral Infection
Zheng, K., Zheng, X., & Yang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843242 · Cited by 56
Wang, X., Cao, Z., Jiang, J., Li, Y., Dong, M., Ostrowski, M., & Cheng, X. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.02.013 · Cited by 54
Integrating Genomic Signatures for Immunologic Discovery
Haining, W. N., & Wherry, E. J. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.001 · Cited by 55
Self-citationShindo, T., Kim, T. K., Benjamin, C. L., Wieder, E., Levy, R. B., & Komanduri, K. V. (2013) · Blood · doi:10.1182/blood-2012-12-476218 · Cited by 54
Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infection
Cella, M., Presti, R. M., Vermi, W., Lavender, K. J., Turnbull, E. L., Ochsenbauer‐Jambor, C., Kappes, J. C., Ferrari, G., Kessels, L., Williams, I. G., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200940234 · Cited by 53
Holst, P. J., Ørskov, C., Thomsen, A. R., & Christensen, J. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900537 · Cited by 54
Sprouty-2 regulates HIV-specific T cell polyfunctionality
Chiu, Y., Shan, L., Huang, H., Haupt, C., Bessell, C. A., Canaday, D. H., Zhang, H., Ho, Y., Powell, J. D., Oelke, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70510 · Cited by 54
Neff, C. P., Chain, J. L., MaWhinney, S., Martin, A. D., Linderman, D. J., Flores, S. C., Campbell, T., Palmer, B. E., & Fontenot, A. P. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1521oc · Cited by 52
Transcription factor regulation of CD8+ T‐cell memory and exhaustion
Angelosanto, J., & Wherry, E. J. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00927.x · Cited by 56
Self-citationThe Microbiome, Systemic Immune Function, and Allotransplantation
Nellore, A., & Fishman, J. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00063-15 · Cited by 54
Signals that drive T follicular helper cell formation
Webb, L. M. C., & Linterman, M. A. (2017) · Immunology · doi:10.1111/imm.12778 · Cited by 55
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
Mhibik, M., Wiestner, A. U., & Sun, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010068 · Cited by 57
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
Doo, D. W., Meza‐Perez, S., Londoño, A. I., Goldsberry, W. N., Katre, A. A., Boone, J. D., Moore, D. J., Hudson, C. T., Betella, I., McCaw, T. R., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920913798 · Cited by 52
Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion
Busselaar, J., Tian, S., van Eenennaam, H., & Borst, J. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.592569 · Cited by 57
Ju, Y.-J., Lee, S., Kye, Y.-C., Lee, G.-W., Kim, H.-O., Yun, C., & Cho, J.-H. (2021) · Nature Communications · doi:10.1038/s41467-021-26351-3 · Cited by 53
Rgs16 promotes antitumor CD8 + T cell exhaustion
Weisshaar, N., Wu, J., Ming, Y., Madi, A., Hotz‐Wagenblatt, A., Ma, S., Mieg, A., Hering, M., Zettl, F., Möhr, K., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abh1873 · Cited by 54
Boukhaled, G. M., Gadalla, R., Elsaesser, H. J., Abd-Rabbo, D., Quevedo, R., Yang, S. Y. C., Guo, M., Wang, B. X., Noamani, B., Gray, D., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01262-7 · Cited by 55
Technology meets TILs: Deciphering T cell function in the -omics era
Hudson, W. H., & Wieland, A. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.09.011 · Cited by 55
Massively parallel knock-in engineering of human T cells
Dai, X., Park, J. J.-Y., Du, Y., Na, Z., Lam, S. Z., Chow, R. D.-W., Renauer, P. A., Gu, J., Shan, X., Chu, Z., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01639-x · Cited by 56
Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+ T and CAR-T cells
Jo, Y., Shim, J. A., Jeong, J. W., Kim, H., Lee, S. M., Jeong, J., Kim, S., Im, S., Choi, D., Lee, B. H., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.08.019 · Cited by 54
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
Huang, Y., Ngiow, S. F., Baxter, A. E., Manne, S., Park, S. L., Wu, J. E., Khan, O., Giles, J. R., & Wherry, E. J. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado3032 · Cited by 57
Self-citationBrown, W. C. (2012) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2011.12.002 · Cited by 53
LAG3 (CD223) and autoimmunity: Emerging evidence
Hu, S., Liu, X., Li, T., Li, Z., & Hu, F. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102504 · Cited by 53
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 56
Marotel, M., Villard, M., Drouillard, A., Tout, I., Besson, L., Allatif, O., Pujol, M., Rocca, Y., Ainouze, M., Roblot, G., et al. (2021) · eLife · doi:10.7554/elife.60095 · Cited by 54
Cai, M., Zhao, X., Cao, M., Ma, P., Chen, M., Wu, J., Jia, C., He, C., Fu, Y., Tan, L., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5435 · Cited by 53
Stem cell like memory T cells: A new paradigm in cancer immunotherapy
Wang, F., Cheng, F., & Fang, Z. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109078 · Cited by 53
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
Weiss, S. A., Huang, A. Y., Fung, M. E., Martínez, D., Chen, C.-Y., LaSalle, T. J., Miller, B. C., Scharer, C. D., Hegde, M., Nguyen, T. H., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01961-3 · Cited by 56
Self-citationChandele, A., Mukerjee, P., Das, G., Ahmed, R., & Chauhan, V. S. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03363.x · Cited by 51
Self-citationGreen, K. A., Cook, W. J., & Green, W. R. (2012) · Journal of Virology · doi:10.1128/jvi.01547-12 · Cited by 51
Distinctive features of CD4+ T cell dysfunction in chronic viral infections
Morou, A., Palmer, B. E., & Kaufmann, D. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000094 · Cited by 52
Srivastava, R., Khan, A. A., Chilukuri, S., Syed, S. A., Tran, T. T., Furness, J. N., Bahraoui, E., & BenMohamed, L. (2017) · Journal of Virology · doi:10.1128/jvi.00278-17 · Cited by 53
Xiong, H., Mittman, S., Rodriguez, R., Pacheco-Sanchez, P., Москаленко, М., Yang, Y., Elstrott, J., Ritter, A. T., Müller, S., Nickles, D., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0750 · Cited by 53
CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
Agresta, L., Lehn, M. A., Lampe, K., Cantrell, R., Hennies, C. M., Szabo, S., Wise-Draper, T. M., Conforti, L., Hoebe, K. H. N., & Janssen, E. M. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000245 · Cited by 52
Macedo, C., Webber, S. A., Donnenberg, A. D., Popescu, I., Hua, Y., Green, M., Rowe, D., Smith, L., Brooks, M. M., & Metes, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001024 · Cited by 52
Mitochondrial respiration is necessary for CD8+ T cell proliferation and cell fate
Steinert, E. M., Bruza, B. F., Danchine, V. D., Grant, R. A., Vasan, K., Kharel, A., Zhang, Y., Cui, W., Szibor, M., Weinberg, S. E., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02202-x · Cited by 56
Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
Flego, M., Ascione, A., Cianfriglia, M., & Vella, S. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-4 · Cited by 53
Loggi, E., Bihl, F. K., Cursaro, C., Granieri, C., Galli, S., Brodosi, L., Furlini, G., Bernardi, M., Brander, C., & Andreoné, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065327 · Cited by 51
Foroushani, A. B. K., Brinkman, F. S. L., & Lynn, D. J. (2013) · PeerJ · doi:10.7717/peerj.229 · Cited by 51
Kean, L. S., Turka, L. A., & Blazar, B. R. (2017) · Immunological Reviews · doi:10.1111/imr.12523 · Cited by 50
Cutting Edge: 2B4-Mediated Coinhibition of CD4+ T Cells Underlies Mortality in Experimental Sepsis
Chen, C., Mittal, R., Klingensmith, N. J., Burd, E. M., Terhorst, C., Martin, G. S., Coopersmith, C. M., & Ford, M. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700375 · Cited by 51
Wang, Q., Pan, W., Liu, Y., Luo, J., Zhu, D. Y., Lu, Y., Feng, X., Yang, X., Dittmer, U., Lu, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00219 · Cited by 57
Expression of novel long noncoding RNAs defines virus-specific effector and memory CD8+ T cells
Hudson, W. H., Prokhnevska, N., Gensheimer, J., Akondy, R. S., McGuire, D. J., Ahmed, R., & Kissick, H. T. (2019) · Nature Communications · doi:10.1038/s41467-018-07956-7 · Cited by 52
Self-citationUse of Mass Cytometry to Profile Human T Cell Exhaustion
Winkler, F., & Bengsch, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03039 · Cited by 54
Spyrou, E., Smith, C. I., & Ghany, M. G. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.01.003 · Cited by 51
Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size
Liu, S. D., Tomassian, T., Bruhn, K. W., Miller, J. F., Poirier, F., & Miceli, M. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803811 · Cited by 51
Guo, Y., Li, Y., Cai, B., He, Q., Chen, G., Wang, M., Wang, K., Wan, X., & Yan, Q. (2021) · Aging · doi:10.18632/aging.202288 · Cited by 51
Williams, E. P., Spruill-Harrell, B., Taylor, M. K., Lee, J., Nywening, A. V., Yang, Z., Nichols, J. H., Camp, J. V., Owen, R. D., & Jonsson, C. B. (2021) · Viruses · doi:10.3390/v13081509 · Cited by 55
Follicular Helper T Cells Promote Liver Pathology in Mice during Schistosoma japonicum Infection
Chen, X., Yang, X., Li, Y., Zhu, J., Zhou, S., Xu, Z., He, L., Xue, X., Zhang, W., Dong, X., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004097 · Cited by 51
Dugast, A., Stamatatos, L., Tonelli, A., Suscovich, T. J., Licht, A. F., Mikell, I., Ackerman, M. E., Streeck, H., Klasse, P. J., Moore, J. P., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344305 · Cited by 50
Hekim, C., Ilander, M. M., Yan, J., Michaud, E., Smykla, R. A., Vähä-Koskela, M. J. V., Savola, P., Tähtinen, S., Saikko, L., Hemminki, A., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0061-t · Cited by 50
CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection
Khairnar, V., Duhan, V., Patil, A., Zhou, F., Bhat, H., Thöns, C., Sharma, P., Adomati, T., Friendrich, S.-K., Bezgovsek, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04832-2 · Cited by 49
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 56
T cell exhaustion is associated with antigen abundance and promotes transplant acceptance
Zou, D., Dai, Y., Zhang, X., Wang, G., Xiao, X., Jia, P., Li, X. C., Guo, Z., & Chen, W. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15870 · Cited by 49
Programmed Cell Death 1-Directed Immunotherapy for Enhancing T-Cell FunctionPreprint
Araki, K., Youngblood, B., & Ahmed, R. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.019869 · Cited by 52
Self-citationImmune Checkpoints in Cancers: From Signaling to the Clinic
Pisibon, C., Ouertani, A., Bertolotto, C., Ballotti, R., & Chéli, Y. (2021) · Cancers · doi:10.3390/cancers13184573 · Cited by 51
Egelston, C. A., Guo, W., Tan, J., Avalos, C., Simons, D. L., Lim, M. H., Huang, Y., Nelson, M. S., Chowdhury, A., Schmolze, D. B., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.153963 · Cited by 56
Dinstag, G., Shulman, E. D., Elis, E., Ben-Zvi, D. S., Tirosh, O., Maimon, E., Meilijson, I., Elalouf, E., Temkin, B., Vitkovsky, P., et al. (2022) · Med · doi:10.1016/j.medj.2022.11.001 · Cited by 49
T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle
Lin, W., Li, H., & Sun, Z. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105154 · Cited by 50
Sun, X., Luo, W.-C., Huang, S., Zheng, Y.-J., Xiao, L., Zhang, Z., Liu, R., Zhong, Z., Song, J., Nan, K., et al. (2025) · Med · doi:10.1016/j.medj.2024.12.003 · Cited by 55
Programmed death-1 as a factor in immune exhaustion and activation in HIV infection
Kaufmann, D., & Walker, B. D. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282f9ae8b · Cited by 47
Chentoufi, A. A., Dervillez, X., Dasgupta, G., Nguyen, C., Kabbara, K. W., Jiang, X., Nesburn, A. B., Wechsler, S. L., & BenMohamed, L. (2012) · Viral Immunology · doi:10.1089/vim.2011.0091 · Cited by 49
Boldison, J., Chu, C. J., Copland, D. A., Lait, P. J. P., Khera, T. K., Dick, A. D., & Nicholson, L. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301390 · Cited by 49
Bolinger, B., Sims, S., Swadling, L., O’Hara, G. A., de Lara, C., Baban, D. F., Saghal, N., Lee, L. N., Marchi, E., Davis, M. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.034 · Cited by 49
Norström, M. M., Rådestad, E., Sundberg, B., Mattsson, J., Henningsohn, L., Levitsky, V., & Uhlin, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8051 · Cited by 49
Menendez, C. M., Jinkins, J. K., & Carr, D. J. J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600207 · Cited by 49
Barton, B. M., Xu, R., Wherry, E. J., & Porrett, P. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0316-135r · Cited by 50
Self-citationDuhan, V., Hamdan, T. A., Xu, H. C., Shinde, P. V., Bhat, H., Li, F., Al-Matary, Y. S., Häussinger, D., Bezgovsek, J., Friedrich, S.-K., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007797 · Cited by 48
Targeting metabolism to reverse T‐cell exhaustion in chronic viral infections
Sears, J. D., Waldron, K. J., Wei, J. N., & Chang, C. (2020) · Immunology · doi:10.1111/imm.13238 · Cited by 51
Immunometabolism in the Tumor Microenvironment
Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 49
Traoré, B., Koné, Y., Doumbo, S., Doumtabé, D., Traoré, A., Crompton, P. D., Mircetic, M., Huang, C., Kayentao, K., Dicko, A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.023 · Cited by 49
Reactive oxygen species delay control of lymphocytic choriomeningitis virus
Lang, P. A., Xu, H. C., Grusdat, M., McIlwain, D. R., Pandyra, A. A., Harris, I. S., Shaabani, N., Honke, N., Maney, S. K., Lang, E., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.167 · Cited by 51
Davenport, B., Bullock, C. B., McCarthy, M. K., Hawman, D. W., MURPHY, K. M. M., Kedl, R. M., Diamond, M., & Morrison, T. E. (2020) · Journal of Virology · doi:10.1128/jvi.02036-19 · Cited by 48
Super-enhancers: Asset management in immune cell genomes
Witte, S. J., O’Shea, J. J., & Vahedi, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.07.005 · Cited by 46
Field, J., Shahijanian, F., Schibeci, S. D., Johnson, L., Gresle, M. M., Laverick, L., Parnell, G. P., Stewart, G. J., McKay, F. C., Kilpatrick, T. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127080 · Cited by 45
Henao-Tamayo, M. I., Irwin, S. M., Shang, S., Ordway, D. J., & Orme, I. M. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.04.001 · Cited by 48
Cytokines and persistent viral infections
Beltra, J., & Decaluwe, H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.02.006 · Cited by 51
Tumino, N., Turchi, F., Meschi, S., Lalle, E., Bordoni, V., Casetti, R., Agrati, C., Cimini, E., Montesano, C., Colizzi, V., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000871 · Cited by 49
CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation
Lingel, H., Wissing, J. B., Arra, A., Schanze, D., Lienenklaus, S., Klawonn, F., Pierau, M., Zenker, M., Jänsch, L., & Brunner-Weinzierl, M. C. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.102 · Cited by 46
Rallón, N. I., García, M., García‐Samaniego, J., Cabello, A., Álvarez, B., Restrepo, C., Nistal, S., Górgolas, M., & Benito, J. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193829 · Cited by 48
Discovery of Small Molecules for the Reversal of T Cell Exhaustion
Marro, B. S., Žák, J., Zavareh, R. B., Teijaro, J. R., Lairson, L. L., & Oldstone, M. B. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.119 · Cited by 47
Metadata
- Authors
- Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R.
- Affiliations
- Emory University (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Wherry, E. John
- Ahmed, Rafi
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 27
- Issue
- 4
- Pages
- 670-684
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2040353461
- Cited by
- 2,103
- References
- 56
- Citations by year
- 2026: 110 · 2025: 148 · 2024: 140 · 2023: 144 · 2022: 139 · 2021: 180 · 2020: 161 · 2019: 138 · 2018: 119 · 2017: 102 · 2016: 112 · 2015: 116 · 2014: 88 · 2013: 83 · 2012: 80
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-11-26)
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2116 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI071309, AI 30048, R01AI071309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- CD8+ T cell exhaustion, chronic viral infection, lymphocytic choriomeningitis virus, PD-1, inhibitory receptors, T cell receptor signaling, cytokine signaling, T cell metabolism, bioenergetics, T cell migration, transcription factors, T cell anergy, gene expression profiling, immunotherapy
- MeSH terms
- Animals, Cell Differentiation, Chronic Disease, Female, Flow Cytometry, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Molecular Sequence Data, Phenotype, Virus Diseases, Gene Expression, Clonal Anergy, CD8-Positive T-Lymphocytes, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review